SAN CARLOS, Calif., December 09, 2025--(BUSINESS WIRE)--ZAP Surgical Systems, Inc., a global leader in non-invasive robotic ...

Daiichi Sankyo showcases strength of industry-leading ADC portfolio with latest research updates from five landmark breast cancer trials at SABCS: Tokyo Tuesday, December 9, 2025, ...

Results from SCOPE to date have enabled Scancell to select Immunobody iSCIB1+, administered needle-free intramuscularly, for further development in patients with selected human leukocyte antigen (HLA) ...

Presentation Title: The ADELA study: A Double-blind, Placebo-controlled, Randomized Phase 3 Trial of Elacestrant (ELA)+ Everolimus (EVE) Versus ELA + Placebo (PBO) in ER+/HER2-Advanced Breast Cancer ...

The terms tumor and cancer can refer to different types of lumps and bumps. But the terms are often confused and misused—by ...

While targeted radiation can be an effective treatment for brain tumors, subsequent potential necrosis of the treated areas ...

While targeted radiation can be an effective treatment for brain tumors, subsequent potential necrosis of the treated areas can be hard to distinguish from the tumors on a standard MRI.

The Menarini Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, ...

While targeted radiation can be an effective treatment for brain tumours, subsequent potential necrosis of the treated areas ...

REVEAL GENOMICS, S.L., a Barcelona-based biotechnology company focused on advancing precision oncology through biomarker ...